Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

Modeling Tumor Clonal Evolution for Drug Combinations Design.

Zhao B, Hemann MT, Lauffenburger DA.

Trends Cancer. 2016 Mar;2(3):144-158. doi: 10.1016/j.trecan.2016.02.001.

2.

Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors.

Albitar A, Ma W, DeDios I, Estella J, Ahn I, Farooqui M, Wiestner A, Albitar M.

Oncotarget. 2017 Mar 14;8(11):17936-17944. doi: 10.18632/oncotarget.15316.

3.

Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies.

Qureshi-Baig K, Ullmann P, Haan S, Letellier E.

Mol Cancer. 2017 Feb 16;16(1):40. doi: 10.1186/s12943-017-0602-2. Review.

4.

Intra-tumor heterogeneity from a cancer stem cell perspective.

Prasetyanti PR, Medema JP.

Mol Cancer. 2017 Feb 16;16(1):41. doi: 10.1186/s12943-017-0600-4. Review.

5.

FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B-cell acute leukemia.

Ishizawa J, Sugihara E, Kuninaka S, Mogushi K, Kojima K, Benton CB, Zhao R, Chachad D, Hashimoto N, Jacamo RO, Qiu Y, Yoo SY, Okamoto S, Andreeff M, Kornblau SM, Saya H.

Blood. 2017 Apr 6;129(14):1958-1968. doi: 10.1182/blood-2016-07-726216. Epub 2017 Jan 31.

PMID:
28143883
6.

Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer.

Jones HG, Jenkins G, Williams N, Griffiths P, Chambers P, Beynon J, Harris D.

World J Surg. 2017 May;41(5):1375-1383. doi: 10.1007/s00268-016-3860-z.

7.

Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.

Qian M, Zhang H, Kham SK, Liu S, Jiang C, Zhao X, Lu Y, Goodings C, Lin TN, Zhang R, Moriyama T, Yin Z, Li Z, Quah TC, Ariffin H, Tan AM, Shen S, Bhojwani D, Hu S, Chen S, Zheng H, Pui CH, Yeoh AE, Yang JJ.

Genome Res. 2017 Feb;27(2):185-195. doi: 10.1101/gr.209163.116. Epub 2016 Nov 30.

PMID:
27903646
8.

Radiation induces the generation of cancer stem cells: A novel mechanism for cancer radioresistance.

Li F, Zhou K, Gao L, Zhang B, Li W, Yan W, Song X, Yu H, Wang S, Yu N, Jiang Q.

Oncol Lett. 2016 Nov;12(5):3059-3065. Epub 2016 Sep 12.

9.

Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia.

Ding LW, Sun QY, Tan KT, Chien W, Thippeswamy AM, Eng Juh Yeoh A, Kawamata N, Nagata Y, Xiao JF, Loh XY, Lin DC, Garg M, Jiang YY, Xu L, Lim SL, Liu LZ, Madan V, Sanada M, Fernández LT, Preethi H, Lill M, Kantarjian HM, Kornblau SM, Miyano S, Liang DC, Ogawa S, Shih LY, Yang H, Koeffler HP.

Cancer Res. 2017 Jan 15;77(2):390-400. doi: 10.1158/0008-5472.CAN-16-1303. Epub 2016 Nov 21. Erratum in: Cancer Res. 2017 Apr 15;77(8):2174.

PMID:
27872090
10.
11.

Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma.

Jiang W, Dulaimi E, Devarajan K, Parsons T, Wang Q, Liao L, Cho EA, O'Neill R, Solomides C, Peiper SC, Testa JR, Uzzo R, Yang H.

PLoS One. 2016 Oct 20;11(10):e0164554. doi: 10.1371/journal.pone.0164554. eCollection 2016.

12.

Emergence of heterogeneity in acute leukemias.

Stiehl T, Lutz C, Marciniak-Czochra A.

Biol Direct. 2016 Oct 12;11(1):51.

13.

Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease.

Issa GC, Kantarjian HM, Yin CC, Qiao W, Ravandi F, Thomas D, Short NJ, Sasaki K, Garcia-Manero G, Kadia TM, Cortes JE, Daver N, Borthakur G, Jain N, Konopleva M, Khouri I, Kebriaei P, Champlin RE, Pierce S, O'Brien SM, Jabbour E.

Cancer. 2017 Feb 1;123(3):459-467. doi: 10.1002/cncr.30376. Epub 2016 Oct 3.

PMID:
27696391
14.

The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.

Mendes RD, Canté-Barrett K, Pieters R, Meijerink JP.

Haematologica. 2016 Sep;101(9):1010-7. doi: 10.3324/haematol.2016.146381. Review.

15.

Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation.

Quentmeier H, Pommerenke C, Ammerpohl O, Geffers R, Hauer V, MacLeod RA, Nagel S, Romani J, Rosati E, Rosén A, Uphoff CC, Zaborski M, Drexler HG.

Oncotarget. 2016 Sep 27;7(39):63456-63465. doi: 10.18632/oncotarget.11524.

16.

Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines.

Salawu A, Fernando M, Hughes D, Reed MW, Woll P, Greaves C, Day C, Alhajimohammed M, Sisley K.

Br J Cancer. 2016 Oct 25;115(9):1058-1068. doi: 10.1038/bjc.2016.259. Epub 2016 Aug 25.

PMID:
27560552
17.

Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma.

Rubinstein JC, Brown TC, Christison-Lagay ER, Zhang Y, Kunstman JW, Juhlin CC, Nelson-Williams C, Goh G, Quinn CE, Callender GG, Udelsman R, Lifton RP, Korah R, Carling T.

BMC Cancer. 2016 Aug 18;16:646. doi: 10.1186/s12885-016-2665-7.

18.

Stem-like features of cancer cells on their way to metastasis.

Gkountela S, Aceto N.

Biol Direct. 2016 Jul 26;11:33. doi: 10.1186/s13062-016-0135-4. Review.

19.

Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias.

Wang K, Sanchez-Martin M, Wang X, Knapp KM, Koche R, Vu L, Nahas MK, He J, Hadler M, Stein EM, Tallman MS, Donahue AL, Frampton GM, Lipson D, Roels S, Stephens PJ, Sanford EM, Brennan T, Otto GA, Yelensky R, Miller VA, Kharas MG, Levine RL, Ferrando A, Armstrong SA, Krivtsov AV.

Leukemia. 2017 Jan;31(1):151-158. doi: 10.1038/leu.2016.166. Epub 2016 Jun 13.

20.

FISHtrees 3.0: Tumor Phylogenetics Using a Ploidy Probe.

Gertz EM, Chowdhury SA, Lee WJ, Wangsa D, Heselmeyer-Haddad K, Ried T, Schwartz R, Schäffer AA.

PLoS One. 2016 Jun 30;11(6):e0158569. doi: 10.1371/journal.pone.0158569. eCollection 2016.

Supplemental Content

Support Center